339 related articles for article (PubMed ID: 20353998)
1. Prostaglandin E2 promotes lung cancer cell migration via EP4-betaArrestin1-c-Src signalsome.
Kim JI; Lakshmikanthan V; Frilot N; Daaka Y
Mol Cancer Res; 2010 Apr; 8(4):569-77. PubMed ID: 20353998
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells.
Han C; Michalopoulos GK; Wu T
J Cell Physiol; 2006 Apr; 207(1):261-70. PubMed ID: 16331686
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2/EP1 signaling pathway enhances intercellular adhesion molecule 1 (ICAM-1) expression and cell motility in oral cancer cells.
Yang SF; Chen MK; Hsieh YS; Chung TT; Hsieh YH; Lin CW; Su JL; Tsai MH; Tang CH
J Biol Chem; 2010 Sep; 285(39):29808-16. PubMed ID: 20647315
[TBL] [Abstract][Full Text] [Related]
4. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
[TBL] [Abstract][Full Text] [Related]
5. Proanthocyanidins inhibit in vitro and in vivo growth of human non-small cell lung cancer cells by inhibiting the prostaglandin E(2) and prostaglandin E(2) receptors.
Sharma SD; Meeran SM; Katiyar SK
Mol Cancer Ther; 2010 Mar; 9(3):569-80. PubMed ID: 20145019
[TBL] [Abstract][Full Text] [Related]
6. Extracellular matrix fibronectin increases prostaglandin E2 receptor subtype EP4 in lung carcinoma cells through multiple signaling pathways: the role of AP-2.
Han S; Ritzenthaler JD; Wingerd B; Rivera HN; Roman J
J Biol Chem; 2007 Mar; 282(11):7961-72. PubMed ID: 17237224
[TBL] [Abstract][Full Text] [Related]
7. Role of beta-arrestin 1 in the metastatic progression of colorectal cancer.
Buchanan FG; Gorden DL; Matta P; Shi Q; Matrisian LM; DuBois RN
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1492-7. PubMed ID: 16432186
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells.
Hsu HH; Lin YM; Shen CY; Shibu MA; Li SY; Chang SH; Lin CC; Chen RJ; Viswanadha VP; Shih HN; Huang CY
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587064
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells.
Pan MR; Hou MF; Chang HC; Hung WC
J Biol Chem; 2008 Apr; 283(17):11155-63. PubMed ID: 18319253
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma.
Su JL; Shih JY; Yen ML; Jeng YM; Chang CC; Hsieh CY; Wei LH; Yang PC; Kuo ML
Cancer Res; 2004 Jan; 64(2):554-64. PubMed ID: 14744769
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 enhances alpha2beta1 integrin expression and cell migration via EP1 dependent signaling pathway in human chondrosarcoma cells.
Liu JF; Fong YC; Chang CS; Huang CY; Chen HT; Yang WH; Hsu CJ; Jeng LB; Chen CY; Tang CH
Mol Cancer; 2010 Feb; 9():43. PubMed ID: 20178602
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation.
Iwanaga K; Okada M; Murata T; Hori M; Ozaki H
J Pharmacol Exp Ther; 2012 Mar; 340(3):604-11. PubMed ID: 22138372
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 receptors EP2 and EP4 are down-regulated in human mononuclear cells after injury.
Strong VE; Winter J; Yan Z; Smyth GP; Mestre JR; Maddali S; Schaefer PA; Yurt RW; Stapleton PP; Daly JM
Surgery; 2001 Aug; 130(2):249-55. PubMed ID: 11490357
[TBL] [Abstract][Full Text] [Related]
14. The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells.
Cherukuri DP; Chen XB; Goulet AC; Young RN; Han Y; Heimark RL; Regan JW; Meuillet E; Nelson MA
Exp Cell Res; 2007 Aug; 313(14):2969-79. PubMed ID: 17631291
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E₂ inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors.
Li YJ; Wang XQ; Sato T; Kanaji N; Nakanishi M; Kim M; Michalski J; Nelson AJ; Sun JH; Farid M; Basma H; Patil A; Toews ML; Liu X; Rennard SI
Am J Respir Cell Mol Biol; 2011 Jan; 44(1):99-107. PubMed ID: 20203295
[TBL] [Abstract][Full Text] [Related]
16. E series of prostaglandin receptor 2-mediated activation of extracellular signal-regulated kinase/activator protein-1 signaling is required for the mitogenic action of prostaglandin E2 in esophageal squamous-cell carcinoma.
Yu L; Wu WK; Li ZJ; Wong HP; Tai EK; Li HT; Wu YC; Cho CH
J Pharmacol Exp Ther; 2008 Oct; 327(1):258-67. PubMed ID: 18583546
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts.
Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S
Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087
[TBL] [Abstract][Full Text] [Related]
18. Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation.
Pozzi A; Yan X; Macias-Perez I; Wei S; Hata AN; Breyer RM; Morrow JD; Capdevila JH
J Biol Chem; 2004 Jul; 279(28):29797-804. PubMed ID: 15123663
[TBL] [Abstract][Full Text] [Related]
19. Cordycepin inhibits lipopolysaccharide-induced cell migration and invasion in human colorectal carcinoma HCT-116 cells through down-regulation of prostaglandin E2 receptor EP4.
Jeong JW; Park C; Cha HJ; Hong SH; Park SH; Kim GY; Kim WJ; Kim CH; Song KS; Choi YH
BMB Rep; 2018 Oct; 51(10):532-537. PubMed ID: 30269738
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1-induced prostaglandin E2-EP2, EP4 signaling regulates vascular endothelial growth factor production and ovarian carcinoma cell invasion.
Spinella F; Rosanò L; Di Castro V; Natali PG; Bagnato A
J Biol Chem; 2004 Nov; 279(45):46700-5. PubMed ID: 15347673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
